Français
ItalianoBond GSK PLC 0% ( US36264FAJ03 ) in USD
| Issuer | GSK PLC | ||||||||
| Market price | 99.98 % ▼ | ||||||||
| Country |  United Kingdom
|
||||||||
| ISIN code |
 US36264FAJ03 ( in USD )
|
||||||||
| Interest rate | 0% | ||||||||
| Maturity | 24/03/2024 - Bond has expired | ||||||||
|
Prospectus brochure in PDF format |
|||||||||
| Minimal amount | 250 000 USD | ||||||||
| Total amount | / | ||||||||
| Cusip | 36264FAJ0 | ||||||||
| Detailed description |
GSK PLC is a British multinational pharmaceutical and biopharmaceutical company headquartered in Brentford, UK, focused on research and development, manufacturing, and marketing of pharmaceuticals, vaccines, and consumer healthcare products globally. A specific fixed-income instrument issued by GSK PLC, the British multinational pharmaceutical and biotechnology powerhouse, recently reached its scheduled maturity. This particular bond, identified by ISIN US36264FAJ03 and CUSIP 36264FAJ0, was a zero-coupon bond denominated in USD, signifying that it did not accrue periodic interest payments but was designed to be purchased at a discount and redeemed at par. Originating from the United Kingdom, the bond had a stated maturity date of March 24, 2024. Prior to its redemption, the bond's last observed market price stood at 99.982% of its par value. The minimum purchase size for this instrument was specified as 250,000 USD. As of its maturity date, the bond has been fully redeemed, concluding its lifecycle within the fixed-income market. |
||||||||
| |||||||||